We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Mara Nissley has a rare disorder that causes her brain to swell as if she has a tumor. Losing weight can help treat the condition, called pseudotumor cerebri. Last year, her doctor recommended she ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep.

(WVUE) - A federal judge’s decision last week to restrict compounding pharmacies from producing tirzepatide, the generic version of Eli Lilly’s weight loss drug Zepbound, has raised concerns ...

Oh, to count the ways we love Brooklinen—especially during Sleep Week 2025! The brand is one of the most trusted shopping destinations year-round for quality home essentials like luxe sheet sets ...

Related Difficult menopause might be warning sign for future dementia Airport, aircraft noise can harm the heart, study says FDA approves weight-loss drug Zepbound to treat sleep apnea Nurses who ...

Be sure to address any sleep disorders, such as sleep apnea, which can harm your health. OK, you already have a tracker (or want one). Use it to see how various life choices affect your sleep ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro.

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. “It’s about the size of a small city,” says David Ricks, Eli Lilly’s CEO. That’s about 10% ...